Skip to main content

Eric Schadt's Network

Pacific Biosciences's Eric Schadt doesn't want to be just a scientist, says this fast-paced Esquire piece, he wants to be a "master of information." Since the one-gene-at-a-time approach doesn't seem to be working, Schadt says, why not look at many genes and proteins and their networks? "The networks between genes and proteins turn out to be organized socially, like human networks, and so human social networks will be required to understand them ... with Eric Schadt at their center," Esquire's Tom Junod writes. Stephen Friend tells Junod that Schadt has sold biologists on complexity. "Eric gets you to understand that it's out of complexity that a pattern derives. That complexity is not the enemy but the vehicle of understanding, and embracing it is how you get there," Friend says.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.